ISTI LOGO
Towards a new dawn
×

img Acces sibility Controls

Technologies Banner

All Technologies

Vaccine for the novel coronavirus, 2019-nCoV (COVID-19) based on two approaches

Implementing Organization

Project Overview

Vaccine for the novel coronavirus, 2019-nCoV (COVID-19) based on two approaches. The first approach deals with development of a DNA vaccine against the major viral membrane protein responsible for the cell entry of the novel coronavirus, now called COVID-19. The second approach deals with development of a live attenuated recombinant measles virus vectored vaccine against COVID-19.

Related Research

View All
Funding Organization
Funding Organization

—

Quick Information
Focus Area
Development of vaccine for COVID-19
Status
1
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
N/A
Startup (If Any)
00
No. of Patents
Filed :00
Grant :00
arrowtop